NCT00181831
- Conditions
- ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +5 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
Clinical trial condition
ADHD
Explore clinical trials studying ADHD. Study availability and eligibility vary by location and protocol.
409 public trials
57 recruiting studies
ADHD trial results
Completed
Attention Deficit Hyperactivity Disorder (ADHD) in Adolescents With Substance Use Disorders (SUD)
NCT00264797
- Conditions
- ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +5 more
- Locations
-
- Synergy Treatment Center Denver, Colorado, United States
- Gateway Community Services Jacksonville, Florida, United States
- Operation PAR, Inc. St. Petersburg, Florida, United States
- Mountain Manor Treatment Programs Baltimore, Maryland, United States
NCT00181714
- Conditions
- ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +7 more
- Locations
-
- Massachusetts General Hospital Cambridge, Massachusetts, United States
NCT01692548
- Conditions
- ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
- Locations
-
- Hospital de Clínicas de Porto Alegre Porto Alegre, Rio Grande do Sul, Brazil
NCT00723684
- Conditions
- ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
- Locations
-
- FC Donders Centre for Cognitive Neuroimaging Nijmegen, Gelderland, Netherlands
- Karakter Nijmegen Nijmegen, Gelderland, Netherlands
NCT00916071
- Conditions
- ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +8 more
- Locations
-
Not specified
NCT00586157
- Conditions
- ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder, +3 more
- Locations
-
- Massachusetts General Hospital Cambridge, Massachusetts, United States
Completed
Study of Atomoxetine and OROS Methylphenidate to Treat Children and Adolescents Ages 6-17 With ADHD
NCT00585910
- Conditions
- ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder, +3 more
- Locations
-
- Massachusetts General Hospital Cambridge, Massachusetts, United States
NCT00253747
- Conditions
- ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +4 more
- Locations
-
- Massachusetts General Hospital Cambridge, Massachusetts, United States
- Mayo Clinic Nicotine Research Program Rochester, Minnesota, United States
- VA New York Harbor Healthcare System New York, United States
- New York State Psychiatric Institute - Smoking Cessation Program New York, United States
NCT00593112
- Conditions
- ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
- Locations
-
- Massachusetts General Hospital Cambridge, Massachusetts, United States